Browsing Tag
THIO-104
1 post
Ateganosine Phase 3 marks inflection point for MAIA Biotechnology with 2026 milestones in focus
Find out how MAIA Biotechnology’s Phase 3 ateganosine trial and 2026 milestones could reshape its regulatory path and investor narrative.